Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism

Background: Recent evidence suggests that the changes in gut microbiota and its metabolites could predict the clinical response of anti-tumor necrosis factor (TNF) agents, such as infliximab (IFX). However, whether manipulation of the gut microbiota can enhance the efficacy of anti-TNF agents remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Fangfei, Dong, Fang, Li, Xiaolu, Li, Youran, Yu, Guangjun, Liu, Zhanju, Wang, Yizhong, Zhang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376241/
https://www.ncbi.nlm.nih.gov/pubmed/35979230
http://dx.doi.org/10.3389/fphar.2022.902337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376241/
https://www.ncbi.nlm.nih.gov/pubmed/35979230
http://dx.doi.org/10.3389/fphar.2022.902337

Ejemplares similares